Fatal Disseminated Tuberculosis during Treatment with Ruxolitinib Plus Prednisolone in a Patient with Primary Myelofibrosis: A Case Report and Review of the Literature

A 73-year-old man with primary myelofibrosis (PMF) was being treated with hydroxyurea, which was changed to ruxolitinib treatment because of worsening constitutional symptoms. Although ruxolitinib rapidly induced relief, he developed a high-grade fever. A comprehensive fever work-up found no apparen...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsukamoto, Yasuhiro, Kiyasu, Junichi, Tsuda, Mariko, Ikeda, Motohiko, Shiratsuchi, Motoaki, Ogawa, Yoshihiro, Yufu, Yuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980814/
https://www.ncbi.nlm.nih.gov/pubmed/29279479
http://dx.doi.org/10.2169/internalmedicine.9165-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980814/
https://www.ncbi.nlm.nih.gov/pubmed/29279479
http://dx.doi.org/10.2169/internalmedicine.9165-17

Ejemplares similares